BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 30334354)

  • 1. Application of immunophenotypic analysis in distinguishing chronic myelomonocytic leukemia from reactive monocytosis.
    Feng R; Bhatt VR; Fu K; Pirruccello S; Yuan J
    Cytometry B Clin Cytom; 2018 Nov; 94(6):901-909. PubMed ID: 30334354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Flow cytometry immunophenotypic features of pure erythroid leukemia and the distinction from reactive erythroid precursors.
    Fang H; Wang SA; You MJ; Hu S; Miranda RN; Tang Z; Lin P; Jorgensen JL; Xu J; Thakral B; Schlette EJ; El Hussein S; Bueso-Ramos C; Medeiros LJ; Wang W
    Cytometry B Clin Cytom; 2022 Nov; 102(6):440-447. PubMed ID: 36156384
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic myelomonocytic leukaemia stem cell transcriptomes anticipate disease morphology and outcome.
    Wiseman DH; Baker SM; Dongre AV; Gurashi K; Storer JA; Somervaille TC; Batta K
    EBioMedicine; 2020 Aug; 58():102904. PubMed ID: 32763828
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characteristics and long-term outcome in a large series of chronic myelomonocytic leukaemia patients including 104 formerly referred to as oligomonocytic.
    Castaño-Díez S; Pomares H; Esteban D; Guijarro F; Jiménez-Vicente C; Zugasti I; Álamo JR; Mayayo VT; López-Guerra M; de la Fuente C; Charry P; Cortés-Bullich A; Bataller Á; Maluquer C; Colomer D; Rozman M; Arnan M; Xicoy B; Esteve J; Díaz-Beyá M
    Br J Haematol; 2024 Mar; 204(3):892-897. PubMed ID: 38013238
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparing malignant monocytosis across the updated WHO and ICC classifications of 2022.
    Baumgartner F; Baer C; Bamopoulos S; Ayoub E; Truger M; Meggendorfer M; Lenk M; Hoermann G; Hutter S; Müller H; Walter W; Müller ML; Nadarajah N; Blombery P; Keller U; Kern W; Haferlach C; Haferlach T
    Blood; 2024 Mar; 143(12):1139-1156. PubMed ID: 38064663
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Germline
    Bochicchio MT; Micucci G; Asioli S; Ghetti M; Simonetti G; Lucchesi A
    Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003211
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Concurrent chronic myelomonocytic leukemia and gastric carcinoma: a case report and literature review.
    Fang C; Chen Z; Li J; Yu L; Wang L
    AME Case Rep; 2023; 7():37. PubMed ID: 37942038
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monocytopenia as a diagnostic clue to pediatric B-lymphoblastic leukemia with rare circulating blasts.
    Park SI; Rogers BB
    Pediatr Dev Pathol; 2013 Jul; ():. PubMed ID: 23815676
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kidney and Urinary Tract Involvement in Chronic Myelomonocytic Leukemia.
    Attieh RM; Begum F; Chitty D; Izzedine H; Jhaveri KD
    Kidney Med; 2024 Feb; 6(2):100769. PubMed ID: 38313809
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Technical, gating and interpretation recommendations for the partitioning of circulating monocyte subsets assessed by flow cytometry.
    Tarfi S; Kern W; Goulas E; Selimoglu-Buet D; Wagner-Ballon O;
    Cytometry B Clin Cytom; 2024 Apr; ():. PubMed ID: 38656036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Temporal trend in survival for chronic myelomonocytic leukemia in the US: a population-based study.
    Lesegretain A; Brunner A; Benzohra A; Fathi AT
    Leuk Lymphoma; 2023 Dec; 64(13):2156-2164. PubMed ID: 37715313
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The first description of a singular case of synchronous chronic myelomonocytic leukemia and diffuse large b-cell lymphoma.
    Romano A; Giusti M; Di Giorgio M; Lumera G; Laura Parrinello N; Cosentino S; Ippolito M; Villari L; Alberto Palumbo G; Di Raimondo F; Santo Signorelli S
    Clin Case Rep; 2021 Sep; 9(9):e03817. PubMed ID: 34589219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lysozyme nephropathy in chronic myelomonocytic leukemia.
    Patel AB; Miles RR; Deininger MW
    Clin Case Rep; 2019 Jun; 7(6):1263-1264. PubMed ID: 31183108
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disappearance of slan-positive non-classical monocytes for diagnosis of chronic myelomonocytic leukemia with associated inflammatory state.
    Tarfi S; Badaoui B; Freynet N; Morabito M; Lafosse J; Toma A; Etienne G; Micol JB; Sloma I; Fenaux P; Solary E; Selimoglu-Buet D; Wagner-Ballon O;
    Haematologica; 2019 Aug; ():. PubMed ID: 31413091
    [No Abstract]   [Full Text] [Related]  

  • 15. Measurable residual disease-guided treatment with azacitidine to prevent haematological relapse in patients with myelodysplastic syndrome and acute myeloid leukaemia (RELAZA2): an open-label, multicentre, phase 2 trial.
    Platzbecker U; Middeke JM; Sockel K; Herbst R; Wolf D; Baldus CD; Oelschlägel U; Mütherig A; Fransecky L; Noppeney R; Bug G; Götze KS; Krämer A; Bochtler T; Stelljes M; Groth C; Schubert A; Mende M; Stölzel F; Borkmann C; Kubasch AS; von Bonin M; Serve H; Hänel M; Dührsen U; Schetelig J; Röllig C; Kramer M; Ehninger G; Bornhäuser M; Thiede C
    Lancet Oncol; 2018 Dec; 19(12):1668-1679. PubMed ID: 30442503
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monocyte subsets to differentiate chronic myelomonocytic leukemia from reactive monocytosis.
    Hwang SM; Ahn H; Jeon S; Park J; Chang Y; Kim H
    J Clin Lab Anal; 2021 Jan; 35(1):e23576. PubMed ID: 32931067
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proposed diagnostic criteria for classical chronic myelomonocytic leukemia (CMML), CMML variants and pre-CMML conditions.
    Valent P; Orazi A; Savona MR; Patnaik MM; Onida F; van de Loosdrecht AA; Haase D; Haferlach T; Elena C; Pleyer L; Kern W; Pemovska T; Vladimer GI; Schanz J; Keller A; Lübbert M; Lion T; Sotlar K; Reiter A; De Witte T; Pfeilstöcker M; Geissler K; Padron E; Deininger M; Orfao A; Horny HP; Greenberg PL; Arber DA; Malcovati L; Bennett JM
    Haematologica; 2019 Oct; 104(10):1935-1949. PubMed ID: 31048353
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A hierarchical approach in the diagnostic workflow of chronic myelomonocytic leukemia: Pivotal role of the "Mono-dysplasia-score" combined with flow cytometric quantification of monocyte subsets.
    Zhu J; Sourdeau E; Aubert H; Clauser S; Maillon A; Capron C; Jondeau K; Ronez E; Schillinger F; Garnache-Ottou F; Cornet E; Bardet V
    Int J Lab Hematol; 2019 Dec; 41(6):782-790. PubMed ID: 31647610
    [TBL] [Abstract][Full Text] [Related]  

  • 19. How I investigate chronic myelomonocytic leukemia.
    Sangiorgio VFI; Arber DA; Orazi A
    Int J Lab Hematol; 2020 Apr; 42(2):101-108. PubMed ID: 31841277
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.